Presumably there are a whole lot of Canadians who are asking their doctors. On safety, any drug that has been obtained from a reputable pharmacy would have passed through many regulators along the way Health Canada approving the drug in the first place, granting the manufacturing facility a licence, the pharmacy has to be approved by a provincial college, etc
Different peptides have vastly different stability profiles once in solution
Clinical data suggest that GLP-1 agonists do not increase recurrent diverticulitis risk in patients whose inflammation has completely resolved
Room temperature storage above 15C accelerates degradation exponentially once the peptide is mixed with water
A PA denial on the drug pulls down the administration code with it in most payer systems
Key Steps Before Starting Semaglutide with Hypothyroidism Before beginning semaglutide, ensure your TSH is stable (typically 0.52.5 mIU/L for most patients) and your levothyroxine dose has not changed for at least 68 weeks